Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 277, Issue 3 46-3, 1999, Pages

  Katovich, Michael J ^a   Gelband, Craig H ^b   Reaves, Phyllis ^b   Wang, Hong Wei ^b   Raizada, Mohan K ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Blood pressure; Renovascular responsiveness

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; PHENYLEPHRINE; POTASSIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE THERAPY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032887928     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.277.3.h1260     Document Type: Article

References (23)

1. Boweles, N. E., R. C. Eisensmith, R. Mohuiddin, M. Pyron, and S. L. C. Woo. A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum. Gene Ther. 7: 1735-1742, 1996.
2. Carr, A. A., and L. M. Prisant. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. J. Clin. Pharmacol. 36: 3-12, 1996.
3. Cody, J. R. Comparing angiotensin-converting enzyme inhibitor trial results in patients with acute myocardial infarction. Arch. Intern. Med. 154: 2029-2036, 1994.
4. Danser, A. H., L. M. Sassen, P. J. Admiraal, F. H. Derkx, P. D. Verdouw, and M. A. Schalekamp Regional production of angiotensin I and II; contribution of vascular kidney-derived renin (Abstract). J. Hypertens. 9, Suppl. 6: S234-S235, 1991.
5. Danser, A. H., J. P. Van Kats, P. J. Admiraal, F. H. Derkx, J. M. Lamers, P. D. Verdouw, P. R. Saxena, and M. A. Schalekamp. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 24: 23-48, 1992.
6. DeDivitiis, O., A. Celentano, G. DeSimone, S. DiSomma, M. Galderisi, V. Liguori, M. De Divitiis, and M. Petitto. Management of the patient with left ventricular hypertrophy. Eur. Heart J. 14: 22-32, 1993.
7. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 299: 373-376, 1980.
8. Gelband, C. H., P. Y. Reaves, J. Evans, H. Wang, M. J. Katovich, and M. K. Raizada. Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension. Hypertension 33: 360-365, 1999.
9. Griendling, K. K., and R. W. Alexander. Angiotensin, other pressors, and the transduction of vascular smooth muscle contraction. In: Hypertension: Pathophysiology, Diagnosis, and Management, edited by J. H. Laragh and B. N. Brenner. New York: Raven, 1990, p. 583-600.
10. Goldfarb, D. A. The renin-angiotensin system. New concepts in regulation of blood pressure and renal function. Urol. Clin. North Amer. 21: 187-194, 1994.
11. Iyer, S. N., D. Lu, M. J. Katovich, and M. K. Raizada. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc. Natl. Acad. Sci. USA 93: 9960-9965, 1996.
12. Kifor, I., and V. J. Dzau. Endothelial renin-angiotensin pathway: evidence for intracellular synthesis and secretion of angiotensins. Circ. Res. 60: 422-428, 1987.
13. Kleber, F. X., L. Niemoller, and W. Doering. Impact of converting enzyme inhibition on progression of chronic heart failure; results of the Munich Mild Heart Failure Trial. Br. Heart J. 67: 289-296, 1992.
14. Lewis, E. J., L. G. Hunsicker, R. P. Bain, and R. D. Rohde. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329: 1456-1462, 1993.
15. 1Rs and angiotensin II action in astroglial and neuronal cells in primary cultures from brain. Proc. Natl. Acad. Sci. USA 92: 1162-1166, 1995.
16. Lu, D., and M. K. Raizada. Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain. Proc. Natl. Acad. Sci. USA 92: 2914-2918, 1995.
17. Lu, D., M. K. Raizada, S. N. Iyer, P. Reaves, H. Yang, and M. J. Katovich. Losartan versus gene therapy. Chronic control of high blood pressure in spontaneously hypertensive rats. Hypertension 30: 363-370, 1997.
18. Martens, J. R., P. Y. Reaves, D. Lu, M. J. Katovich, K. H. Berecek, S. P. Bishop, M. K. Raizada, and C. H. Gelband. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy. Proc. Natl. Acad. Sci. USA 95: 2664-2669, 1998.
19. Pfeffer, M. A. ACE inhibition in acute myocardial infarction. N. Engl. J. Med. 332: 118-120, 1995.
20. 1) receptor gene. Eur. Heart J. 15: 108-112, 1994.
21. Ruilope, L. M., V. Lahera, J. L. Rodicio, and J. C. Romero. Are renal hemodynamics a key factor in the development and maintenance of arterial-hypertension in humans? Hypertension 23: 3-9, 1994.
22. Tschudi, M. R., G. Noll, U. Arnet, D. Novosel, D. Ganten, and T. F. Luscher. Alterations in coronary artery vascular reactivity of hypertensive ren-2 transgenic rats. Circulation 89: 2780-2786, 1994.
23. Vogt, M., W. H. Motz, B. Schwartzkopf, and B. E. Strauer. Pathophysiology and clinical aspects of hypertensive hypertrophy. Eur. Heart J. 14: 2-7, 1993.